Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 11/2015

01-11-2015 | Dementia (KS Marder, Section Editor)

Using Administrative Data to Examine Health Disparities and Outcomes in Neurological Diseases of the Elderly

Author: Allison W. Willis

Published in: Current Neurology and Neuroscience Reports | Issue 11/2015

Login to get access

Abstract

The fields of neurodegenerative disease and dementia research have grown considerably in the last several decades. Due to tremendous efforts of basic and clinical research scientists, we know a great deal about dementia risk factors and have multiple treatment options. Clinician recognition of cognitive impairment has increased considerably, national policies which support screening for and documenting cognitive dysfunction now exist, and public awareness of neurodegenerative disease has never been greater. These conditions promote (and demand) the growth of translational epidemiology and health services research, which focuses on examining outcomes in groups of individuals as a function of health care experiences. This review discusses the use of administrative data to answer health care outcomes and disparities questions in dementia. Of particular interest are publically available datasets that contain varying amounts of diagnostic, clinical, pharmacy, and patient information. Methodological challenges that are frequently encountered and must be understood to minimize biased inference are also discussed.
Literature
1.
2.
Willis AW, Schootman M, Kung N, Racette BA. Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson’s Disease in the United States. Parkinsonism Relat Disord. 2013;19:202–6.PubMedCentralCrossRefPubMed
3.
Wright WA, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34:143–51.CrossRef
4.
Pope G, Ellis R, Ash A, et al. Diagnostic cost group hierarchical condition category models for Medicare risk adjustment. Final Report. 2015.
5.
Centers for Medicare and Medicaid Services. National Plan and Provider Enumeration System (NPPES). 2014.
6.•
Faurot KR, Jonsson FM, Pate V, et al. Using claims data to predict dependency in activities of daily living as a proxy for frailty. Pharmacoepidemiol Drug Saf. 2015;24:59–66. A major difficulty with using non-enriched or basic administrative claims data to examine health care experiences and outcomes in chronic or progressive neurological disease is the inability to access functional data. This reference demonstrates how global and specific disability can be assessed and adjusted for in claims data studies.CrossRefPubMed
7.
Kim DH, Schneeweiss S. Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations. Pharmacoepidemiol Drug Saf. 2014;23:891–901.PubMedCentralCrossRefPubMed
8.
Covinsky KE, Hilton J, Lindquist K, Dudley RA. Development and validation of an index to predict activity of daily living dependence in community-dwelling elders. Med Care. 2006;44:149–57.CrossRefPubMed
9.
Taylor Jr DH, Fillenbaum GG, Ezell ME. The accuracy of medicare claims data in identifying Alzheimer’s disease. J Clin Epidemiol. 2002;55:929–37.CrossRefPubMed
10.•
Koller D, Bynum JP. Dementia in the USA: state variation in prevalence. J Public Health (Oxf). 2014. This study indirectly hightlights an often understudied issue of “big data” studies- spatial autocorrelation- the tendency of people/physicians/hospitals in the same area to have similar testing/diagnosis/treatment/health behavior patterns. Using national datasets may require adjustment for regional factors such as physician/specialist supply, presence of academic medical centers, or even consideration of neighborhood factors such as safety, walkability, transportation.
11.
Lin PJ, Fillit HM, Cohen JT, Neumann PJ. Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders. Alzheimers Dement. 2013;9:30–8.CrossRefPubMed
12.
Daiello LA, Gardner R, Epstein-Lubow G, Butterfield K, Gravenstein S. Association of dementia with early rehospitalization among Medicare beneficiaries. Arch Gerontol Geriatr. 2014;59:162–8.CrossRefPubMed
13.
Givens JL, Mitchell SL, Kuo S, Gozalo P, Mor V, Teno J. Skilled nursing facility admissions of nursing home residents with advanced dementia. J Am Geriatr Soc. 2013;61:1645–50.PubMedCentralCrossRefPubMed
14.
Wilcock DM, Gharkholonarehe N, Van Nostrand WE, Davis J, Vitek MP, Colton CA. Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer’s disease. J Neurosci. 2009;29:7957–65.PubMedCentralCrossRefPubMed
15.
Besson FL, La JR, Doeuvre L, et al. Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer’s disease. J Neurosci. 2015;35:10402–11.CrossRefPubMed
16.
Toga AW, Foster I, Kesselman C, et al. Big Biomedical data as the key resource for discovery science. J Am Med Inform Assoc. 2015;21.
17.
Weiner MW, Veitch DP, Aisen PS, et al. Impact of the Alzheimer’s disease neuroimaging initiative, 2004 to 2014. Alzheimers Dement. 2015;11:865–84.CrossRefPubMed
18.
Saykin AJ, Shen L, Yao X, et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: progress, opportunities, and plans. Alzheimers Dement. 2015;11:792–814.CrossRefPubMed
19.
Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 2014;82:163–71.PubMedCentralCrossRefPubMed
20.
Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology. 2007;68:267–71.CrossRefPubMed
21.
Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301:63–73.PubMedCentralCrossRefPubMed
22.
Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9:581–91.PubMedCentralCrossRefPubMed
23.
Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov Disord. 2010;25:578–86.CrossRefPubMed
24.
Gisbert R, Schenkman M. Physical therapist interventions for Parkinson disease. Phys Ther. 2015;95:299–305.CrossRefPubMed
25.
26.
Woods B, Spector A, Jones C, Orrell M, Davies S. Reminiscence therapy for dementia. Cochrane Database Syst Rev. 2005;2.
27.
28.
Kaiser Family Foundation. Medicare Part D Facts. 2015.
29.•
Lai EC, Wong MB, Iwata I, et al. Risk of pneumonia in new users of cholinesterase inhibitors for dementia. J Am Geriatr Soc. 2015;63:869–76. This study is an example of how recently avalable claims datasets, such as Medicare + Medicare part D prescription data, can be used to perfrom pharmacovigilence and comparative effectiveness research. To draw causal inferences requires more advanced mothodologies.CrossRefPubMed
30.
Spector A, Davies S, Woods B, Orrell M. Reality orientation for dementia: a systematic review of the evidence of effectiveness from randomized controlled trials. Gerontologist. 2000;40:206–12.CrossRefPubMed
31.
32.
Hill J, Fillit H, Thomas SK, Chang S. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer’s disease and other dementias. PharmacoEconomics. 2006;24:265–80.CrossRefPubMed
33.•
Gell NM, Wallace RB, LaCroix AZ, Mroz TM, Patel KV. Mobility device use in older adults and incidence of falls and worry about falling: findings from the 2011–2012 national health and aging trends study. J Am Geriatr Soc. 2015;63:853–9. This is one of many studies that has made use of an enriched administraive claims dataset, the National Health and Aging Tends Study. Disease specific information or existing registry data can be linked to administraive claims data to produce enriched datasets capable of 1) expanding the questions that can be answered using registry datasets, 2) examining selection bias in registry populations 3) improving generalizability of registry based studies, and 4) generating algorithims than can adjust for clinical disease features using claims data.CrossRefPubMed
34.
Kim K, Lehning AJ, Sacco P. Assessing the factor structure of well-being in older adults: findings from the National Health and Aging Trends Study. Aging Ment Health. 2015;27:1–9.
35.
Wolff JL, Spillman B. Older adults receiving assistance with physician visits and prescribed medications and their family caregivers: prevalence, characteristics, and hours of care. J Gerontol B Psychol Sci Soc Sci. 2014;69 Suppl 1:S65–72.CrossRefPubMed
36.
Choi NG, DiNitto DM. Role of new diagnosis, social isolation, and depression in older adults’ smoking cessation. Gerontologist. 2014.
37.
Choi NG, Kim J, Marti CN, Chen GJ. Late-life depression and cardiovascular disease burden: examination of reciprocal relationship. Am J Geriatr Psychiatr. 2014;22:1522–9.CrossRef
38.
Skolarus LE, Burke JF, Freedman VA. The role of accommodations in poststroke disability management. J Gerontol B Psychol Sci Soc Sci. 2014;69 Suppl 1:S26–34.CrossRefPubMed
39.
Hunt LJ, Covinsky KE, Yaffe K, et al. Pain in community-dwelling older adults with dementia: results from the National Health and Aging Trends Study. J Am Geriatr Soc. 2015;22.
Metadata
Title
Using Administrative Data to Examine Health Disparities and Outcomes in Neurological Diseases of the Elderly
Author
Allison W. Willis
Publication date
01-11-2015
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 11/2015
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-015-0595-4